Search

Kavita Rangan Phones & Addresses

  • San Diego, CA
  • Murrieta, CA
  • Livermore, CA
  • New York, NY

Work

Company: University of california, san diego Aug 2019 Position: Postdoctoral researcher

Resumes

Resumes

Kavita Rangan Photo 1

Postdoctoral Researcher

View page
Location:
San Diego, CA
Work:
University of California, San Diego
Postdoctoral Researcher

Publications

Us Patents

Chemical Reporters Of Protein Acylation

View page
US Patent:
20100203647, Aug 12, 2010
Filed:
Nov 20, 2009
Appl. No.:
12/623335
Inventors:
HOWARD C. HANG - NEW YORK NY, US
GUILLAUME CHARRON - NEW YORK NY, US
JOHN P. WILSON - NEW YORK NY, US
ANURADHA RAGHAVAN - NEW HAVEN CT, US
MINGZI ZHANG - NEW YORK NY, US
YU-YING YANG - STAMFORD CT, US
KAVITA RANGAN - NEW YORK NY, US
LUN K. TSOU - NEW YORK NY, US
JACOB YOUNT - BROOKLYN NY, US
Assignee:
THE ROCKEFELLER UNIVERSITY - New York NY
International Classification:
G01N 33/00
C09B 29/00
C07C 245/24
US Classification:
436 86, 534752, 534551
Abstract:
Methods and kits for detecting acylated proteins produced by cells that have been cultured or by cells within an organism are provided. Also provided are methods and kits for detecting acylated proteins produced by cells where affinity purification tags are that facilitate detection are used. Compounds useful for the detection of acylated proteins are also provided.

Modified Microorganisms Expressing Saga As Anti-Infective Agents, Probiotics And Food Components

View page
US Patent:
20190211067, Jul 11, 2019
Filed:
Apr 22, 2016
Appl. No.:
15/568726
Inventors:
- New York NY, US
Kavita RANGAN - New York NY, US
Daniel MUCIDA - New York NY, US
Virginia PEDICORD - New York NY, US
International Classification:
C07K 14/315
A61K 35/744
A61P 31/04
A23L 33/135
A23C 9/123
A23C 9/12
A23K 10/18
Abstract:
Provided are compositions and methods based in part on the discovery that heterologous secreted antigen A (SagA)-produced peptidoglycan fragments are protective against enteric bacterial infections. Modified bacteria that are engineered to express heterologous SagA are provided, and are included a nutraceutical, pharmaceutical, and probiotic formulations, and as components of food products, including dairy products. The modified bacteria include modified bacteria that express heterologous SagA. The disclosure includes a method that involves introducing into an individual modified bacteria of that express and secrete heterologous SagA. The disclosure provides isolated peptidoglycan fragment preparations made by a exposing a composition that contains peptidoglycan to an isolated or recombinant SagA, or to modified bacteria expressing a heterologous SagA, allowing SagA to generate the peptidoglycan fragments, and separating the peptidoglycan fragments from the composition to obtain the isolated peptidoglycan fragments or a preparation that contains them.
Kavita J Rangan from San Diego, CA, age ~37 Get Report